WO2008095623A3 - LUCIFÉRASE SÉCRÉTÉE Lu164M3 ET SON UTILISATION - Google Patents

LUCIFÉRASE SÉCRÉTÉE Lu164M3 ET SON UTILISATION Download PDF

Info

Publication number
WO2008095623A3
WO2008095623A3 PCT/EP2008/000625 EP2008000625W WO2008095623A3 WO 2008095623 A3 WO2008095623 A3 WO 2008095623A3 EP 2008000625 W EP2008000625 W EP 2008000625W WO 2008095623 A3 WO2008095623 A3 WO 2008095623A3
Authority
WO
WIPO (PCT)
Prior art keywords
lu164m3
secreted luciferase
secreted
luciferase
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2008/000625
Other languages
German (de)
English (en)
Other versions
WO2008095623A2 (fr
Inventor
Stefan Golz
Eugene Vysotski
Svetlana Markova
Ludmila Frank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of WO2008095623A2 publication Critical patent/WO2008095623A2/fr
Publication of WO2008095623A3 publication Critical patent/WO2008095623A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La présente invention concerne la séquence de nucléotides et d'acides aminés, ainsi que l'activité et l'utilisation de la Lu164M3, ainsi que l'utilisation de luciférases sécrétées.
PCT/EP2008/000625 2007-02-06 2008-01-26 Luciférase sécrétée lu164m3 et son utilisation Ceased WO2008095623A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007005804.9 2007-02-06
DE200710005804 DE102007005804A1 (de) 2007-02-06 2007-02-06 Sekretierte Luziferase Lu164M3 und deren Verwendung

Publications (2)

Publication Number Publication Date
WO2008095623A2 WO2008095623A2 (fr) 2008-08-14
WO2008095623A3 true WO2008095623A3 (fr) 2008-11-20

Family

ID=39323759

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/000625 Ceased WO2008095623A2 (fr) 2007-02-06 2008-01-26 Luciférase sécrétée lu164m3 et son utilisation

Country Status (2)

Country Link
DE (1) DE102007005804A1 (fr)
WO (1) WO2008095623A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT508478B1 (de) 2009-06-26 2012-01-15 Tdw Delaware Inc Sensorarray für die inspektion der innenwand eines rohres
WO2012071631A1 (fr) 2010-12-03 2012-06-07 Gene Stream Pty Ltd Molécules électroluminescentes améliorées
CN116536354A (zh) * 2022-09-27 2023-08-04 中国水产科学研究院黄海水产研究所 一种欧洲海鲈npffr2重组质粒、细胞系及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042470A1 (fr) * 2000-11-23 2002-05-30 Bayer Aktiengesellschaft Luciferases isolees et leur utilisation
WO2006061906A1 (fr) * 2004-12-09 2006-06-15 Nec Soft, Ltd. Gene codant pour une nouvelle luciferase

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002042470A1 (fr) * 2000-11-23 2002-05-30 Bayer Aktiengesellschaft Luciferases isolees et leur utilisation
WO2006061906A1 (fr) * 2004-12-09 2006-06-15 Nec Soft, Ltd. Gene codant pour une nouvelle luciferase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARKOVA S V ET AL: "Cloning and Expressing of cDNA for a Luciferase from the Marine Copepod Metrida longa", JOURNAL OF BIOLOGICAL CHEMISTRY, AL, vol. 279, no. 5, 30 January 2004 (2004-01-30), pages 3212 - 3217, XP002986384, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2008095623A2 (fr) 2008-08-14
DE102007005804A1 (de) 2008-08-07

Similar Documents

Publication Publication Date Title
WO2008095622A3 (fr) Luciférase secrétée mluc7 et son utilisation
IL200407A0 (en) Stable digestive enzyme compositions, methods of producing the same and uses thereof
WO2010077740A3 (fr) Nouveaux composés antiviraux, compositions et procédés d'utilisation
WO2005097825A3 (fr) Variants de bmp-7 ayant des proprietes ameliorees
WO2008097619A3 (fr) Variants de la phytase de buttiauxella sp. dotés de propriétés modifiées
IL204621A0 (en) Bicyclic - ?? - amino acid derivatives, compositions comprising the same and uses thereof
IL210589A0 (en) The tuberculosis rv2386c protein, compositions and uses thereof
WO2009037473A3 (fr) Caractérisation de nucléobases
WO2008151032A3 (fr) Ensembles et procédés comprenant des produits géniques de m. smithii
WO2009077471A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
WO2009089120A3 (fr) Marqueurs génétiques de maladie mentale
WO2009039189A3 (fr) Compositions comprenant des arnsi de stat3 et leurs procédés d'utilisation
WO2008143668A3 (fr) Indoléamine-2, 3-dioxygénase-2
WO2010135836A8 (fr) Nouvelles enzymes bêta-glucosidases
WO2009002440A3 (fr) Compositions comprenant un arnsi de egfr humain et leurs procédés d'utilisation
WO2009100183A3 (fr) Variantes des phytases de buttiauxella sp. à propriétés modifiées
WO2011029866A3 (fr) Compositions de polymérase et utilisations
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2009115252A3 (fr) Pyrazolamides substitués et leur utilisation
EP2285953A4 (fr) Compositions d'arn polyphosphatase, trousses et utilisations associées
WO2008148932A3 (fr) Procédé pour le traitement de cancers ou de maladies inflammatoires
BRPI0719836A2 (pt) Clonagem, expressão e uso de fosfolipases ácidas.
WO2008095623A3 (fr) LUCIFÉRASE SÉCRÉTÉE Lu164M3 ET SON UTILISATION
WO2009143277A3 (fr) Compositions comprenant un arnsi hscn9a et leurs procédés d'utilisation
WO2008152252A3 (fr) Peptides rumc présentant une activité antimicrobienne

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08707331

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08707331

Country of ref document: EP

Kind code of ref document: A2